211 related articles for article (PubMed ID: 35795144)
41. Analyze and compare the predictors of ipsilateral central lymph node metastasis in papillary thyroid carcinoma with cT1a and cT1b stage.
Zhou B; Wei L; Qin J
Asian J Surg; 2021 Nov; 44(11):1357-1362. PubMed ID: 33715963
[TBL] [Abstract][Full Text] [Related]
42. Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: A systematic review and meta-analysis.
Ma B; Wang Y; Yang S; Ji Q
Int J Surg; 2016 Apr; 28():153-61. PubMed ID: 26944586
[TBL] [Abstract][Full Text] [Related]
43. Application of decision tree algorithms to predict central lymph node metastasis in well-differentiated papillary thyroid carcinoma based on multimodal ultrasound parameters: a retrospective study.
Wan F; He W; Zhang W; Zhang H; Zhang Y; Guang Y
Quant Imaging Med Surg; 2023 Apr; 13(4):2081-2097. PubMed ID: 37064365
[TBL] [Abstract][Full Text] [Related]
44. Shorter distance between the nodule and capsule has greater risk of cervical lymph node metastasis in papillary thyroid carcinoma.
Wang QC; Cheng W; Wen X; Li JB; Jing H; Nie CL
Asian Pac J Cancer Prev; 2014; 15(2):855-60. PubMed ID: 24568507
[TBL] [Abstract][Full Text] [Related]
45. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
46. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
47. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
[TBL] [Abstract][Full Text] [Related]
48. Pediatric thyroid cancer: Risk factors for central lymph node metastasis in patients with cN0 papillary carcinoma.
Ngo DQ; Ngo QX; Van Le Q
Int J Pediatr Otorhinolaryngol; 2020 Jun; 133():110000. PubMed ID: 32200312
[TBL] [Abstract][Full Text] [Related]
49. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.
Li X; Zhang H; Zhou Y; Cheng R
World J Surg Oncol; 2021 Apr; 19(1):138. PubMed ID: 33941214
[TBL] [Abstract][Full Text] [Related]
50. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
Nie X; Tan Z; Ge M
BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
[TBL] [Abstract][Full Text] [Related]
51. Analysis of the risk factors for central lymph-node metastasis of cN0 papillary thyroid microcarcinoma: A retrospective study.
Liu J; Fan XF; Yang M; Huang LP
Asian J Surg; 2022 Aug; 45(8):1525-1529. PubMed ID: 34642055
[TBL] [Abstract][Full Text] [Related]
52. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.
Li M; Zhu XY; Lv J; Lu K; Shen MP; Xu ZL; Wu ZS
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3801-3807. PubMed ID: 28975988
[TBL] [Abstract][Full Text] [Related]
53. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1.
Jianming L; Jibin L; Linxue Q
Eur J Radiol; 2020 Feb; 123():108801. PubMed ID: 31918249
[TBL] [Abstract][Full Text] [Related]
54. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
55. Machine Learning Algorithms for the Prediction of Central Lymph Node Metastasis in Patients With Papillary Thyroid Cancer.
Wu Y; Rao K; Liu J; Han C; Gong L; Chong Y; Liu Z; Xu X
Front Endocrinol (Lausanne); 2020; 11():577537. PubMed ID: 33193092
[TBL] [Abstract][Full Text] [Related]
56. Correlation Analysis of Nodular Sonographic Parameters with Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma.
Zhou L; Zhu Q; Yao J; Yang C; Xu D
Biomed Res Int; 2022; 2022():4680064. PubMed ID: 35607302
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis.
Wen X; Jin Q; Cen X; Qiu M; Wu Z
World J Surg Oncol; 2022 Apr; 20(1):106. PubMed ID: 35365171
[TBL] [Abstract][Full Text] [Related]
58. Risk factors for right paraesophageal lymph node metastasis in papillary thyroid carcinoma: A meta-analysis.
Shao L; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T; Qin Y
Surg Oncol; 2020 Mar; 32():90-98. PubMed ID: 31987575
[TBL] [Abstract][Full Text] [Related]
59. Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1-2 Central Lymph Node Metastases.
Wang Y; Deng C; Shu X; Yu P; Wang H; Su X; Tan J
Front Endocrinol (Lausanne); 2021; 12():716728. PubMed ID: 34721289
[TBL] [Abstract][Full Text] [Related]
60. A model based on clinical data and multi-modal ultrasound for predicting cervical lymph node metastasis in patients with thyroid papillary carcinoma.
Wang B; Cao Q; Cui XW; Dietrich CF; Yi AJ
Front Endocrinol (Lausanne); 2022; 13():1063998. PubMed ID: 36578956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
